Pathophysiological mechanisms and treatment of red blood cell abnormalities
Multi-user equipment approved in grant 19/18886-1: PeriCam PSI NR
Neutrophil heterocellular aggregates in sickle cell disease: a possible target for...
Investigation of the inflammasome formation in patients with sickle cell anemia
Inflammatory mediators, interaction with eosinophils and tyrosine kinase inhibitor...
PIEZO1 in sickle cell disease: role in erythrocyte and inflammatory cell function